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N E U R O P H Y S I O L O G I C A L C H A R A C T E R I Z A T I O N O F O P I O I D P E P T I D E 
A C T I O N S O N N E U R O H U M O R A L T R A N S M I S S I O N IN T H E M A M M A L I A N 
C E N T R A L N E R V O U S S Y S T E M 
W. Zieglgänsberger, N. Mercuri, P. Stanzione, and B . Sutor 
I N T R O D U C T I O N 
In the mammalian central nervous system, Opioid agonists induce changes in physiological 
Parameters, and alter behavior, mood. and mental processes as well as endocrine and au-
toregulatory Functions. The most extensive studies have certainly been carried out on the 
analgesic actions of Opioids. The effects of systemically or topically applied Opioid agonists 
are dose dependent, show stereoselectivity. and are reversed by Opioid antagonists such as 
naloxone or naltrexone. The stereoselectivity of Opioid effects suggested that stereoselective 
receptors existed on neuronal tissue where endogenous ligands are operative under phys-
iological conditions. 
Since the discovery of the first endogenous ligand for the Opioid receptor. some 20 
endogenous Opioid peptides have been isolated and characterized that mimic the naloxone 
reversible effects of Opioids in bioassays for Opioid activity or compete at low concentrations 
with Opioid ligands at Opioid binding sites. The various endorphins probably serve diverse 
physiological functions.1 This view is supported by their different and rather specific dis-
tribution in the nervous system and their origin from different precursor molecules.2 Fur-
thermore, different Opioid peptides interact with a different spectrum of Opioid receptor-
subclasses,3 which are also distributed in a rather specific manner in the nervous system. 
A survey of present data suggests that no simple anatomical or functional link exists 
between the endorphinergic system and a particular neurotransmitter system in the mam-
malian central nervous system. The enkephalins are mainly contained in short-axoned in-
terneurons which are present at all levels of the neuraxis. In contrast, ß-endorphin-reactive 
material is almost exclusively found to originate from the basal Hypothalamus and adjacent 
tissue, and project paraventricularly to mesencephalic sites. Dynorphin fibers from the 
Hypothalamus project to cortical and limbic arcas, the midbrain and mesencephalon, and 
are also contained in groups of interneurons including spinal cord dorsal horn neurons. 1 4 
The rather restricted distribution of, e.g., ß-endorphin does not, however, preclude an action 
on remote neurons carrying opioid receptors. It has been postulated that Opioid peptides are 
released into the circulation, e.g., after psychic or physical Stressors have been applied, 
from brain sites as well as the adrenal medulla.5 Their specific distribution in nerve terminals, 
their release after synaptic Stimulation, and the distinct actions exerted by some of the opioid 
peptides on neuronal Systems suggest that they are involved in Information transfer as 
intercellular messengers in certain parts of the mammalian central nervous system. There is 
evidence from various investigations in the vertebrate as well as the invertebrate nervous 
system that, besides fast synaptic transmission triggered by the rapid opening and closing 
of ionic Channels, processes which have a significantly slower time course take place at 
synaptic sites. Neuropeptides are considered to be major candidates for involvement in such 
modulatory mechanisms where, e.g., a substance without directly influencing membrane 
potential or membrane conductance transiently alters the responsiveness of a neuron to 
transmitters released from adjacent terminals. Such findings support the notion that the 
borderline between neurosecretion and neurotransmission is less clear than previously thought. 
In general, the activation of opioid receptors in the mammalian central and peripheral 
nervous system evokes an inhibition of spontaneous and chemically or synaptically induced 
neuronal discharge activity. Considerable uncertainties still exist regarding the mode of 
action of Opioids on single neurons. In this chapter, results of studies on the action of opioid 
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peptides on neurons from the adult rat cortex, from hippocampus. and from the adult spinal 
cord of the rat will be reported. 
M A T E R I A L S A N D M E T H O D S 
Single Unit Recording 
Most of the Information we have gathered so far about the actions of neuropeptides in 
the central nervous system (CNS) derive from extracellular recording of single unit activity 
in combination with iontophoretic administration from micropipettes or by microsuperfusion 
from multibarreled electrodes. It is obvious that extracellular recordings only show the 
influence of a substance on suprathreshold neuronal phenomenon. In order to analyze the 
ionic mechanisms underlying the action of neuropeptides, it is necessary to record intra-
cellularly and to apply the Compounds in the near vicinity of the neuron under study. These 
technically difficult studies have been limited so far to a few types of mammalian neurons. 
The introduction of in vitro preparations of the mammalian has introduced interesting 
possibilities in the analysis of peptide actions and their interactions with classical neuro-
transmitters (for technical details see Reference 6). In these preparations, a large proportion 
of the afferent fibers remains intact so that some of the neurons can be identified by afferent 
Stimulation. Furthermore. the pharmacological actions of the neuroactive Compounds can 
be analyzed without the interference of anesthesia or paralyzing agents. Lowering the C a 2 ' 
concentration and increasing the M g 2 * concentration of the superfusion medium or adding 
the spike-blocking neurotoxin tetrodotoxin effectively reduces or blocks synaptic transmis-
sion so that drug actions can be studied on a synaptically isolated neuron. Together with 
recordings from invertebrates, whose neurons are accessible to even more elaborate elec-
trophysiological techniques and of which some species possess enkephalin-containing neu-
rons (see this volume), this approach will gain considerable relevance for the analysis of 
opioid actions. 
Microiontophoresis and Microsuperfusion from Multibarreled Pipettes 
The microiontophoretic application of a neuroactive substance circumvents the diffusional 
limits set by the blood-brain barrier. Furthermore, it reduces indirect effects arising from 
influences upon remote neurons and from actions secondary to metabolic and circulatory 
disturbances after, e.g., systemic applications. The concentrations reached at the receptor 
site by phoretic application of the opioid peptides (or other substances) are virtually unknown, 
although the number of molecules transported is linearly related to the current flowing through 
the micropipette.7 
This major disadvantage of the microiontophoretic administration technique can be at least 
partially overcome by ejection of diluted Solutions from micropipettes by pressure appli-
cation. This microsuperfusion technique does not require high pressure, typically 10 to 50 
kPa or measurement of the volume ejected. It was established recently that the effective 
concentrations of opioid peptides reached at the receptor sites with the application of com-
monly used phoretic currents (50 to 300 nA) from pipettes filled with 10 m M Solutions of 
the opioid compare favorably to those opioid concentrations used in various bioassays such 
as the guinea pig ileum and the mouse vas deferens* (Figure 1). The effective concentrations 
for the excitatory amino acid neurotransmitter L-glutamate (GLU) were established to be in 
the ränge of 10 7 to 10 6 M (Figure 2). 
R E S U L T S 
Cortex 
Most areas of the neocortex of mammals contain enkephalin or other opioid peptide-
reactive material and the presence of multiple opioid receptor Subtypes has been demonstrated 
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F I G U R E I. Depressant efTect o f D A D L on a neuron in the dorsal horn o f the rat spinal cord . The activation o f this neuron by short pulses 
o f G L U (30 n A / 2 0 sec) was reversibly bloeked by microsuperfusion (20 kPa) o f D A D L (10 7 M ) . Th i s cITecl was prevented by simultaneous 
administrat ion o f naloxone (10 " M ) ejected from the samc multibarreled mieropipel le . T i m e cal ibrat ion: 2 m i n . 
44 CRC Hemdbook of C o m p a r a t i v e O p i o i d a n d Related Neuropeptide Mechanisms 
10, 
sp/s 
o' GLU 15nA GLU 2-10" 6M 20s 
F I G U R E 2. Alternate microiontophoret ic and pneumatic ap-
pl icat ion o f G L U . The spontaneously discharging dorsal horn 
neuron reee iv ing mul t imoda l input from cutaneous reeeptive 
fields was recorded in rat anesthetized by halothane (for tech-
nical details see Reference 37). T o establish the effective con-
centrations o f micro ion tophore t ica l ly appl ied G L U (from 0.5 
m M Solut ion) , the amino ac id was ejected alternately by phoresis 
(bars) or by pressure (30 kPa) (dotted lines) from micropipettes 
containing G L U at different concentrations. The effective con-
centration reached by a phoretic current o f 15 n A for G L U 
corresponded to concentrations of 2 x 10 h M . Note: this 
concentrat ion is the m a x i m a l concentration at the orif ice o f the 
pipette; the concentra t ion at the receptor is probably lower. 
in cortical struetures (see "Introduction"). The prominent initial response of neurons re-
corded in various sites in the cortex to microiontophoretically applied opioid peptides is a 
reduetion in their spontaneous firing rate or in the discharge activity of these neurons induced 
by short iontophoretic pulses (5 to 100 nA/5 to 20 sec) of excitatory neurotransmitters such 
as G L U or acetylcholine. 9 1 0 In a microiontophoretic study, where morphine was used as a 
selective mu-agonist and D-Ala 2-D-Leu 5-enkephalin (DADL; a synthetic enkephalin congener 
which is resistant to enzymatic degradation) was used as a prototypic delta-agonist, con-
vincing evidence was obtained that these inhibitory responses were mediated by various 
Subtypes of the opioid receptor.10 
Short-term iontophoretic applications ofeither opioid resulted in adaptive processes which 
were similar to tolerance to and dependence on opioid agonists occurring after chronic 
treatment. When the delta-receptor agonist was applied after the cell had been desensitized 
to the mu-agonist, the potency of D A D L to produce inhibition of firing was unchanged, 
i.e., no cross-desensitization was exhibited. These studies on the Single unit level showed 
for the first time that different Subtypes of Opioid receptors can be located on the same 
cel l .* 1 0 Multiplicity of opioid receptors was initially suggested by the different patterns of 
opioid and opioid peptide activity in various assay Systems." 
In a subsequent study, the effect of D A D L on neurons in a slice preparation12 obtained 
from the rat sensory-motor cortex was examined. In these in vitro studies, intracellular 
recordings were obtained from neocortical cells that displayed membrane potentials between 
65 to 75 mV, input resistances between 10 to 20 M H , and action potentials with amplitudes 
between 80 to 120 mV. Stable, long-lasting intracellular recordings could be obtained from 
these neurons. The enkephalin-analog D A D L and the opioid antagonist naloxone were 
applied iontophoretically, by ejection from pressurized micropipettes, or added to the su-
perfusion medium, after a postimpalement control period during which the membrane Po-
tential was stable for 15 to 30 min. In none of the neurons tested did the application of 
D A D L change the membrane potential more than 2 mV or alter the membrane resistance 
of the neuron. D A D L applied topically in concentrations of 10" 8 to 10" 6 M reduced the 
amplitude and the rate of rise of the EPSP evoked by Stimulation in superficial layers about 
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1 to 2 mm remote to the recording site. Bath-applied naloxone (10 h M) reversed or prevented 
this effect which was clearly dose dependent. Short microiontophoretic pulses of G L U or 
aspartate (10 to 80 nA/10 to 20 sec) were clearly reduced or blocked by D A D L applied 
phoretically (40 to 200 nA/1 to 5 min) or added to the medium (10 " 8 to 10 6 M). Most 
importantly, this anti-GLU effect of D A D L was not altered when the neuron was synaptically 
uncoupled by superfusing the slice with a medium that contained 9 mM M g 2 4 and no C a 2 + . 
These latter findings indicate that the opioid receptors activated by D A D L are located on 
the neuron recorded from. 
To test for the reversal potential of this opioid peptide the effect of D A D L was tested at 
various membrane potential levels. As under resting conditions, D A D L had no effect on 
the membrane potential displaced by intracellular current injection. When D A D L was applied 
during depolarizations (5 to 20 mV) induced by continuous phoretic application of G L U , 
the membrane potential was repolarized by D A D L . Findings similar to these described for 
D A D L have also been obtained with morphine.12 The sum of these results suggests that 
D A D L and morphine have a modulatory effect on the actions of excitatory amino acid 
neurotransmitters like G L U which preferentially increases the permeability of the cell to 
Na* ions . n 
In contrast to the modulatory effect of D A D L , the phoretic application of G A B A (5 to 
150 nA) was associated with a marked reduction of neuronal input resistance. Depending 
on the membrane potential, the decrease in input resistance was associated with depolarizing 
or hyperpolarizing changes in membrane potential. The reversal potential for this action of 
G A B A was found to be essentially identical to the C l equilibrium potential (between —69 
and - 74 mV) and the reversal potential was shifted in the depolarizing direction by intra-
cellular injection of C l . These findings suggest that the decrease in cell input resistance 
produced by G A B A is due to a selective increase in membrane permeability to C L . These 
actions of G A B A were dose dependent and could be reversibly blocked by bicuculline ( 1 0 - 5 
M) added to the superfusion medium. 1 4 
Hippocampus 
Unlike most other CNS structures, the CA1 region of the hippocampus (HC) predominantly 
responds to the application of opioid agonists with a profound increase in hippocampal 
pyramidal cell (HCP) excitability 1 5- 1 6 which might be the basis for the observed limbic 
seizure activity. 1 7 1 8 It was first postulated from extracellular recordings that this excitatory 
response results from an inhibition of inhibitory GABAergic interneurons. , 9 - 2 ( ) This inhibitory 
action of opioid agonists on adjacent interneurons which leads to a disinhibition of HCP 
neurons was substantiated by subsequent intracellular studies in in vitro slice preparations21 2 2 
and organotypic cell culture Systems23 where it was shown that Opioid agonists markedly 
reduce the IPSP following alveus or Stratum radiatum Stimulation. The excitation evoked in 
HCP by the various opioid alkaloids and opioid peptides is mediated by multiple receptor 
mechanisms.24 In a recent study, it was observed that D A D L and the dynorphin A (1-17) 
( D Y N A) fragment, D Y N A (1-13), which is considered a kappa-preferring ligand, increase 
the excitability of HCP in the C A 1 and CA2 regions. This increase in excitability is associated 
with a reduction of the inhibition produced by orthodromic Stimulation of the Stratum ra-
diatum. D Y N A (1-17) at concentrations between 10" 5 and 10~7 M reduced the excitability 
of HCP in CA2 and decreased the excitatory effect of D A D L in CA1 pyramidal cells in 
vitro. At low concentrations (10 1 0 M ) , D Y N A (1-17) preferentially increased HCP excit-
ability and mimicked the actions of the other opioid peptides. The excitatory effect of D A D L 
and D Y N A (1-13) was antagonized by bath-applied naloxone ( 1 0 - 6 to 10~5 M). The 
depressant actions of D Y N A (1-17) on HCP excitability were not antagonized by naloxone 
added to the superfusion medium. D Y N A (1-13) was shown to cause excitation at sites in 
the hippocampal pyramidal layer where D Y N A (1 -17) evoked a depression of the population 
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spike amplitude. The Observation that D Y N A (1-17) potentially modulates the activity of 
D A D L on the sarne neuron population is suggestive of a partial antagonistic action of D Y N 
A (l-17). 3 s From the present results. however, the possibility of a functional antagonism 
cannot be excluded. 
Spinal Cord 
Opioid peptides and most of the other recently characterized neuropeptides have been 
localized in cell bodies and terminals of the substantia gelatinosa (SG). Peptidergic mech-
anisms have been implicated in the control exerted by interneurons in the SG over cells 
which give rise to spinofugal projections. Most spinofugally projecting neurons receiving 
multimodal synaptic input from peripheral receptive fields were inhibited by Opioids" 
(Figure I). 
Extracellular recording performed from neurons of the SG in an in vitro preparations from 
the spinal cord of adult rats" showed that about 40% of the neurons was spontaneously 
active. Interestingly, they could be synaptically influenced by Stimulation of fibers entering 
the spinal cord through either the dorsal or ventral roots. Repetitive low threshold Stimulation 
transiently activated a substantial number of these neurons, whereas high intensity Stimulation 
predominately reduced the excitability of SG neurons. These effects were slow in onset and 
had a slow time course for recovery. As in other structures in vivo and in vitro, activity 
evoked by phoretically administered G L U as well as synaptically induced and spontaneous 
activity was reduced or abolished by the opioid peptides (and G A B A ) . The actions of D A D L 
(30 to 200 nA/1 to 5 min) were blocked by phoretically applied naloxone (50 to 100 nA/2 
to 3 min). 
Several mechanisms have been proposed by which the depressant effects of Opioids are 
produced. One is a presynaptic effect where the release of excitatory transmitters is dccreased 
by Opioids; a second is a postsynaptic modulatory effect on the efficacy of an excitatory 
neurotransmitter substance; and a third suggests a hyperpolarizing action associated with a 
conductance change at the target neuron. At present, most electrophysiological and ultra-
structural data indicate that the major effects of Opioids on central neurons are probably 
mediated via postsynaptically located opioid receptors. Before the morphological demon-
stration of axodendritic, axosomatic. or dendrodendritic enkephalinergic synapses,23 3 1 a 
postsynaptic site of action of Opioids was indicated solely by electrophysiological invesli-
gations demonstrating that depolarizations produced by iontophoretic application of G L U 
could be markedly reduced by opioid peptides.7 3 2 Opioid peptides reduce the rise time of 
EPSPs both in spinal cord neurons and cortical neurons. without influencing the membrane 
potential of the membrane resistance.13 Such a decrease in rise time of the EPSP induced 
by Opioids would be much more effective in blocking spike initiation triggercd in dorsal 
horn neurons by slowly rising synaptic potentials (mainly repetitive firing in C-fibers) than 
those produced by powerful fast-rising excitatory postsynaptic potentials evoked by S t i m u -
lation of large fiber inputs. Observations compatible with the assumption of such a preferential 
effect of Opioids on excitatory postsynaptic potentials have been made in cortical. striatal. 
and bulbar respiratory neurons,33 and such an effect appears to be a characteristic feature 
of opioid action. The rather selective effect of opioid agonists on noxious mechanical, 
thermal, and chemical Stimulation may be explained in terms of the characteristics of changes 
in the rise time of postsynaptic potentials. A substantial number of neurons in the substantia 
gelatinosa of the dorsal horn of the rat spinal cord studied in vitro were found to be 
hyperpolarized by opioid peptides. An increase in K-conductance has been suggested to 
underlie this effect.36 
S U M M A R Y A N D C O N C L U S I O N S 
Opioid peptides seem to be involved in many diverse funetions in the vertebrate and 
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invertebrate nervous system.34 For many classes of mammalian CNS neurons, it remains to 
be established whether the preferentially inhibitory action of Opioids on neuronal activity is 
exerted by a modulatory effect on the action of excitatory transmitters, e.g., G L U , 1 3 by a 
transmitter-like hyperpolarizing effect which involves potassium-conductance increase35 or 
by other possible mechanisms. It should be pointed out that the mechanism of action of 
different Opioids is not necessarily the same, and that the mechanism of action of any Single 
opioid may be different for different types of CNS neurons. Although immunohistochemical 
and ultrastructural data do not support a presynaptic interaction of opioid peptides with 
primary afferents or other afferent terminals via axo-axonic synapses, evidence for a pre-
synaptic action of Opioids has been presented and actions of Opioids at nonsynaptic receptors 
are of course possible. 
Before a biologically active agent can be established as a neurotransmitter or neuromo-
dulator, several criteria must be satisfied: location in nerve terminals, release after Stimu-
lation, machinery for synthesis. and termination of action. As further evidence for a 
neurotransmitter role of a certain substance in the CNS, ligand binding experiments are 
used. To prove the identity of action of an exogenous Compound with synaptically released 
substance, intracellular recordings are necessary and selective Stimulation of a given pathway 
has to be achieved. Such technically difficult studies have been tried only in a few groups 
of mammalian neurons so far. At present, no peptidergic system in the mammalian CNS 
can be stimulated selectively. In the case of the Opioid peptides, the reversibility of an 
evoked response by naloxone or the absence of action in the morphine-tolerant State is often 
the only indication for the involvement of an endorphinergic link. The relatively simple 
nervous system of the invertebrates might offer new experimental perspectives in the analysis 
of the physiological role of opioid peptides. Opioid binding sites do exist in some invertebrate 
species34 and opioid peptides have been found in distinct cell groups (see Leung and Stefano, 
this volume). The accessibility of these neuronal circuits to elaborate Stimulation and re-
cording techniques could provide important experimental tools for the elucidation of opioid 
peptide actions and the opioid Syndrome in general. 
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